Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors

Anticancer Research

Volumn 28, Issue 1 B, 2008, Pages 367-372

  Vallbohmer D ^a   Marcus, H E ^a   Baldus, S E ^a   Brabender, J ^a   Lurje, G ^a   Drebber, U ^b   Metzger, R ^a   Holscher A H ^a   Schneider, Paul M ^a,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Classification systems; Gastrointestinal stromal tumors; Prognosis

Indexed keywords

IMATINIB; KI 67 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ABDOMINAL PAIN; ADJUVANT THERAPY; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DYSPHAGIA; FATIGUE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESENCHYMOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY; TUMOR VOLUME;

GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MITOSIS; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE;

EID: 40549143380     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rubin BP: Gastrointestinal stromal tumours: an update. Histopathology 48: 83-96, 2006.
2. Corless CL, Fletcher JA and Heinrich MC: Biology of gastrointestinal stromal tumors. J Clin Oncol 22: 3813-3825, 2004.
3. Appelman HD: Smooth muscle tumors of the gastrointestinal tract: what we know now that Stout did not know. Am J Surg Pathol 10 Suppl 1: 83-99, 1986.
4. Fletcher CD, Berman JJ, Corless C et al: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33: 459-465, 2002.
5. Mazur MT and Clark HB: Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 7: 507-519, 1983.
6. Miettinen M, Virolainen M and Maarit Sarlomo R: Gastrointestinal stromal tumors: value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol 19: 207-216, 1995.
7. Miettinen M and Lasota J: Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438: 1-12, 2001.
8. Raut CP, Posner M, Desai J et al: Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol 24: 2325-2331. 2006.
9. Franquemont DW: Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 103: 41-47, 1995.
10. Miettinen M, El-Rifai W, HL Sobin L and Lasota J: Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a Review. Hum Pathol 33: 478-483, 2002
11. Emory TS, Sobin LH, Lukes L, Lee DH and O'Leary TJ: Prognosis of gastrointestinal smooth-muscle (stromal) tumors. Dependance on anatomic site. Am J Surg Pathol 23: 82-87, 1999
12. Miettinen M, Blay JY and Sobin LH: Mesenchymal tumours of the stomach. In: World Health Organization Classification of Tumours. Pathology and Genetics of the Digestive System. 1st ed. Hamilton SR, Aaltonen LA (eds.). IARC Press, Lyon, France, pp. 62-65, 2000.
13. Rudolph P, Gloeckner K, Parwaresch R, Harms D and Schmidt D: Immunophenotype, proliferation, DNA ploidy, and biological behaviour of gastrointestinal stromal tumors: a multivariate clinicopathologic study. Hum Pathol 29: 791-800, 1998.
14. Wong NA, Young R, Malcomson RD et al: Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 43: 118-126, 2003.
15. Tornoczky T, Kover E and Pajor L: Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours. J Clin Pathol 56: 363-367, 2003.
16. Goldblum JR and Appelman HD: Stromal tumors of the duodenum. A histologic and immunohistochemical study of 20 cases. Am J Surg Pathol 19: 71-80, 1995.
17. Parfitt JR, Streutker CJ, Riddell RH and Driman DK: Gastrointestinal stromal tumors: a contemporary review. Pathol Res Pract 12: 837-847, 2006.
18. Andersson J, Bumming P, Meis-Kindblom JM et al: Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis. Gastroenterology 130: 1573-1581, 2006.
19. Heinrich MC, Rubin BP, Longley BJ et al: Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol 33: 484-495, 2002.
20. DeMatteo R, Owzar K, Maki R et al and the American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team: Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup Phase III trial ACOSOG Z9001. J Clin Oncol, ASCO Annual Meeting Proceedings Part I. 25, 18S: 10079, 2007.